Nisa Investment Advisors LLC grew its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 20,936.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 426,206 shares of the health services provider's stock after buying an additional 424,180 shares during the quarter. Nisa Investment Advisors LLC owned 0.25% of Teladoc Health worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently bought and sold shares of the company. Point72 Asset Management L.P. grew its stake in Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock worth $76,803,000 after purchasing an additional 3,063,172 shares in the last quarter. Clearline Capital LP boosted its stake in shares of Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock valued at $42,682,000 after buying an additional 3,483,665 shares during the period. Geode Capital Management LLC grew its position in shares of Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after buying an additional 56,864 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in shares of Teladoc Health during the third quarter worth approximately $15,801,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock valued at $15,617,000 after acquiring an additional 228,004 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.
Shares of TDOC stock opened at $10.06 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock's 50-day moving average price is $10.01 and its 200 day moving average price is $9.04. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $21.74.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Several research analysts have commented on the stock. Evercore ISI boosted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. The Goldman Sachs Group started coverage on Teladoc Health in a report on Friday, November 15th. They issued a "buy" rating and a $14.00 target price on the stock. Piper Sandler reaffirmed an "overweight" rating and set a $13.00 price target (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. TD Cowen lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research report on Friday, November 1st. Fourteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $12.08.
Check Out Our Latest Stock Report on Teladoc Health
In related news, insider Carlos Nueno sold 2,389 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.95% of the stock is currently owned by company insiders.
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.